WuXi CFO Edward Hu to Discuss VC Funding at BIO China

WuXi CFO Edward Hu will share his thoughts on early-stage venture capital funding at BIO China in November. As head of WuXi Corporate Venture Fund, Hu pays close attention to the...

WuXi SVP Chris Chen to Deliver Keynote Speech at IBC’s BioProcess International China...

WuXi  executive Dr. Chris Chen is to deliver the keynote speech at IBC’s BioProcess  International China Conference in August. Chen, Senior Vice President  and Chief Technology Officer, Biologics Services at WuXi,...

WuXi Global Webinar – “Demystifying Product Development in China”

Overview China’s fast growing healthcare market represents a significant opportunity for pharmaceutical and biotechnology companies to develop and launch therapies. By capitalizing on local research, development, manufacturing, and regulatory know-how, companies can design and...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease...

We are thrilled about WuXi NextCODE's contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood...